Redpoint Bio Corporation, a development stage biotechnology company, focuses on the development of healthier foods and new approaches for the treatment of diabetes and obesity by understanding the biology of taste and its relationship to metabolism, satiety, and diabetes. It enters into a license and commercialization agreement with International Flavors and Fragrances Inc. for the development, manufacture, use, and commercialization of RP44, which is a component of the stevia plant that works as a sweetness enhancer amplifying the existing sugary sweetness in a food or beverage. The company is based in Philadelphia, Pennsylvania.
Industry, Sector and Symbol
Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Phone215-456-2312
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Redpoint Bio (OTCMKTS:RPBC) Frequently Asked Questions
What is Redpoint Bio's stock symbol?
Redpoint Bio trades on the OTCMKTS under the ticker symbol "RPBC."
Has Redpoint Bio been receiving favorable news coverage?
Media coverage about RPBC stock has been trending positive recently, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Redpoint Bio earned a daily sentiment score of 3.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Redpoint Bio.
Who are some of Redpoint Bio's key competitors?
Some companies that are related to Redpoint Bio include Iqvia (IQV), Incyte (INCY), EXACT Sciences (EXAS), Icon (ICLR), Charles River Laboratories Intl. (CRL), PRA Health Sciences (PRAH), Syneos Health (SYNH), Exelixis (EXEL), BTG (BTGGF), Medpace (MEDP), National Research (NRC), Intrexon (XON), Sorrento Therapeutics (SRNE), STARPHARMA HOLD/S (SPHRY) and Auxly Cannabis Group (CBWTF).
What other stocks do shareholders of Redpoint Bio own?
Who are Redpoint Bio's key executives?
Redpoint Bio's management team includes the folowing people:
- Dr. R. Kyle Palmer Ph.D., Sr. Director of Discovery Research
How do I buy shares of Redpoint Bio?
Shares of RPBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Redpoint Bio's stock price today?
One share of RPBC stock can currently be purchased for approximately $0.00.
What is Redpoint Bio's official website?
How can I contact Redpoint Bio?
Redpoint Bio's mailing address is 7 GRAPHICS DRIVE, EWING NJ, 08628. The company can be reached via phone at 215-456-2312.
MarketBeat Community Rating for Redpoint Bio (OTCMKTS RPBC)
MarketBeat's community ratings are surveys of what our community members think about Redpoint Bio and other stocks. Vote "Outperform" if you believe RPBC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RPBC will underperform the S&P 500 over the long term. You may vote once every thirty days.
